Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. (Q44885739)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. |
scientific article |
Statements
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice (English)
Christine B Yoo
Jody C Chuang
Allen S Yang
Louis Dubeau
Tiffany Long
Peter W Laird
Victor E Marquez
Peter A Jones
19 March 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference